0,990  0,001  TNF expression inhibitor
0,990  0,002  Respiratory analeptic
0,987  0,001  Androgen antagonist
0,980  0,001  Embryotoxic
0,978  0,000  UGT2B15 substrate
0,977  0,001  Teratogen
0,973  0,001  Sensitization
0,974  0,002  Carcinogenic
0,972  0,000  UGT2B7 substrate
0,972  0,004  Antiinflammatory
0,968  0,002  CYP2C9 substrate
0,962  0,001  Sulfotransferase substrate
0,958  0,002  Analeptic
0,954  0,000  UGT2B4 substrate
0,956  0,003  UDP-glucuronosyltransferase substrate
0,947  0,002  CYP3A4 substrate
0,945  0,003  Eye irritation, high
0,938  0,001  UGT1A4 substrate
0,937  0,001  Androgen agonist
0,937  0,002  Hypoxia-inducible factor 1 alpha inhibitor
0,937  0,003  CYP2C19 substrate
0,932  0,004  Antiallergic
0,922  0,000  Transcortin receptor antagonist
0,921  0,002  Hair growth stimulant
0,923  0,004  Transcription factor NF kappa B inhibitor
0,909  0,002  NOS3 expression inhibitor
0,895  0,003  NOS2 expression inhibitor
0,892  0,003  Carcinogenic, group 3
0,884  0,004  CYP1A2 substrate
0,880  0,000  UGT2B11 substrate
0,873  0,002  Muscular dystrophy treatment
0,869  0,004  Mutagenic
0,863  0,002  Antipruritic
0,859  0,000  UGT2B9 substrate
0,851  0,003  Proliferative diseases treatment
0,835  0,004  CYP2C19 inhibitor
0,817  0,001  Progesterone antagonist
0,807  0,005  Antiasthmatic
0,800  0,001  Glucocorticoid antagonist
0,802  0,006  Antihypercholesterolemic
0,795  0,001  Antipruritic, allergic
0,794  0,002  Aromatase inhibitor
0,790  0,005  Toll-Like receptor 7 agonist
0,785  0,005  Toll-Like receptor agonist
0,773  0,003  Diuretic
0,782  0,019  Apoptosis agonist
0,767  0,004  AR expression inhibitor
0,763  0,002  Antieczematic
0,749  0,001  Glucocorticoid agonist
0,750  0,005  Skin irritative effect
0,748  0,005  Cholesterol antagonist
0,744  0,003  Anesthetic general
0,744  0,004  Immunosuppressant
0,739  0,001  Aldosterone antagonist
0,726  0,005  UGT1A9 substrate
0,713  0,001  Lipocortins synthesis antagonist
0,714  0,003  Endometrios treatment
0,707  0,002  Contraceptive
0,720  0,022  Caspase 9 stimulant
0,702  0,005  UGT1A1 substrate
0,689  0,004  Prostatic (benign) hyperplasia treatment
0,685  0,004  Anesthetic
0,682  0,005  Inflammatory Bowel disease treatment
0,678  0,001  Interferon gamma antagonist
0,672  0,000  Antipruritic, non-allergic
0,673  0,004  Allergic rhinitis treatment
0,666  0,006  UGT1A6 substrate
0,662  0,009  CTGF expression inhibitor
0,672  0,019  Antiarthritic
0,661  0,013  Prostate cancer treatment
0,656  0,008  Antiosteoporotic
0,657  0,010  Bone diseases treatment
0,658  0,012  Aldehyde oxidase inhibitor
0,644  0,002  Antineoplastic, alkylator
0,663  0,025  Antineoplastic (breast cancer)
0,635  0,002  Contraceptive female
0,623  0,003  Interleukin 8 antagonist
0,630  0,010  CYP2D6 substrate
0,624  0,005  P-glycoprotein inhibitor
0,619  0,005  CYP3A4 inhibitor
0,601  0,002  Abortion inducer
0,586  0,001  UGT2B10 substrate
0,582  0,003  Contraceptive male
0,583  0,013  Cytostatic
0,581  0,014  Chemopreventive
0,559  0,004  NOS3 expression enhancer
0,554  0,004  Antiacne
0,564  0,016  Cytotoxic
0,545  0,005  Rhinitis treatment
0,544  0,005  Diabetic retinopathy treatment
0,542  0,003  Postmenopausal disorders treatment
0,529  0,003  Prostate disorders treatment
0,528  0,003  Estrogen receptor alpha antagonist
0,519  0,004  Interleukin 6 antagonist
0,512  0,000  Arachidonic acid antagonist
0,512  0,001  Anabolic
0,527  0,020  Chemoprotective
0,505  0,004  Sodium/bile acid cotransporter inhibitor
0,514  0,014  Cardiodepressant
0,505  0,011  ICAM1 expression inhibitor
0,505  0,013  Chronic obstructive pulmonary disease treatment
0,495  0,006  Antihypotensive
0,493  0,004  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,489  0,002  Growth stimulant
0,496  0,014  DNA synthesis inhibitor
0,501  0,027  Antineoplastic (ovarian cancer)
0,472  0,003  Cushing's syndrome treatment
0,484  0,017  Nitric oxide antagonist
0,483  0,023  Antipsoriatic
0,474  0,014  Antidiabetic symptomatic
0,481  0,021  Interleukin antagonist
0,461  0,005  Psychosexual dysfunction treatment
0,455  0,003  Mineralocorticoid receptor antagonist
0,457  0,006  VCAM1 expression inhibitor
0,465  0,017  Antineoplastic (lymphoma)
0,445  0,001  Postcoital contraceptive
0,430  0,002  5-Alpha-reductase inhibitor
0,432  0,004  Estrogen antagonist
0,457  0,029  Hepatic disorders treatment
0,452  0,029  Radioprotector
0,444  0,029  Antineoplastic (pancreatic cancer)
0,413  0,007  Alkylator
0,410  0,004  Cholesterol synthesis inhibitor
0,435  0,030  Apoptosis antagonist
0,408  0,003  Alcohol dehydrogenase substrate
0,452  0,050  Antileukemic
0,401  0,000  Corticosteroid-like
0,438  0,040  Immunostimulant
0,417  0,023  Interleukin 2 agonist
0,392  0,010  Antialcoholic
0,404  0,023  Antihypoxic
0,387  0,007  Toxic, respiratory center
0,403  0,023  Antineoplastic (liver cancer)
0,391  0,012  Melanin inhibitor
0,432  0,058  Antineoplastic (lung cancer)
0,379  0,004  Estrogen agonist
0,375  0,004  LDLR expression enhancer
0,396  0,036  Antioxidant
0,386  0,027  Antineoplastic (renal cancer)
0,390  0,031  DNA damaging
0,364  0,012  Lipid peroxidase inhibitor
0,350  0,007  Antihyperlipoproteinemic
0,344  0,002  RNA-directed RNA polymerase stimulant
0,368  0,027  Antineoplastic (endocrine cancer)
0,379  0,040  Antineoplastic (cervical cancer)
0,363  0,032  Antineoplastic (osteosarcoma)
0,380  0,050  Caspase 3 stimulant
0,364  0,036  Cardiovascular analeptic
0,367  0,042  Antineoplastic (glioma)
0,325  0,004  Menstruation disorders treatment
0,337  0,016  UGT1A3 substrate
0,367  0,048  Antineoplastic (melanoma)
0,406  0,087  Cyclophilin D inhibitor
0,406  0,087  Antidiabetic
0,320  0,006  Topoisomerase II alpha inhibitor
0,313  0,002  Progesterone agonist
0,358  0,049  Antineoplastic (brain cancer)
0,328  0,023  Hepatoprotectant
0,309  0,005  Age-related macular degeneration treatment
0,319  0,016  Monophenol monooxygenase inhibitor
0,310  0,008  UGT2B1 substrate
0,335  0,037  Angiogenesis stimulant
0,336  0,038  Antineoplastic (glioblastoma multiforme)
0,402  0,104  Antineoplastic (solid tumors)
0,313  0,016  Topoisomerase II inhibitor
0,294  0,001  Lipocortins synthesis agonist
0,319  0,033  Antineoplastic enhancer
0,326  0,045  Tumour necrosis factor alpha release inhibitor
0,284  0,007  Antiinfertility, female
0,312  0,036  Antineoplastic (sarcoma)
0,367  0,093  Antibacterial
0,277  0,007  SULT1A1 substrate
0,271  0,004  Estradiol 17 beta-dehydrogenase inhibitor
0,273  0,009  Farnesoid X receptor antagonist
0,266  0,004  Estrogen receptor alpha agonist
0,261  0,003  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,267  0,014  DNA intercalator
0,277  0,026  Neurotrophic factor enhancer
0,265  0,015  Antifungal enhancer
0,267  0,017  Glutathione S-transferase substrate
0,267  0,017  Adenylate cyclase inhibitor
0,252  0,007  Estrogen receptor beta antagonist
0,249  0,007  AMP-activated protein kinase stimulant
0,244  0,004  Premenstrual syndrome treatment
0,242  0,003  5-Alpha-reductase 1 inhibitor
0,253  0,014  Antineoplastic antibiotic
0,248  0,014  Carcinogenic, group 2B
0,257  0,032  Antieczematic atopic
0,225  0,005  SULT1E1 substrate
0,237  0,020  VEGF expression inhibitor
0,298  0,083  Immunomodulator
0,234  0,020  DNA polymerase I inhibitor
0,272  0,060  Acute neurologic disorders treatment
0,291  0,084  Antifungal
0,208  0,003  5-Alpha-reductase 2 inhibitor
0,262  0,063  Antiglaucomic
0,203  0,005  Estrogen receptor beta agonist
0,198  0,003  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,277  0,083  Cardioprotectant
0,269  0,076  Renal disease treatment
0,212  0,019  Interleukin 4 antagonist
0,219  0,029  Genotoxic
0,184  0,003  Na+ K+ transporting ATPase inhibitor
0,266  0,089  Antiepileptic
0,187  0,010  Inducible nitric-oxide synthase inhibitor
0,177  0,002  Glucose-6-phosphate dehydrogenase inhibitor
0,181  0,007  Interleukin 5 antagonist
0,176  0,003  Antihyperaldosteronism
0,193  0,021  Microtubule formation inhibitor
0,246  0,077  Myocardial infarction treatment
0,172  0,004  Anticholelithogenic
0,289  0,124  CYP2C9 inhibitor
0,292  0,128  Rheumatoid arthritis treatment
0,182  0,021  Choleretic
0,179  0,019  Pregnane X receptor agonist
0,199  0,040  Antirickettsial
0,221  0,062  Antiviral (Influenza)
0,196  0,046  Antiviral (Influenza A)
0,155  0,006  Glycine receptor antagonist
0,169  0,020  Antineoplastic (uterine cancer)
0,163  0,015  Toll-Like receptor 4 antagonist
0,193  0,045  Acetylcholine M1 receptor antagonist
0,150  0,005  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,168  0,023  Constipation treatment
0,145  0,004  Estrone sulfatase inhibitor
0,188  0,049  Amylase inhibitor
0,161  0,022  Ca2+-transporting ATPase inhibitor
0,163  0,024  Antineoplastic alkaloid
0,171  0,032  Autism spectrum disorders treatment
0,215  0,078  Antiulcerative
0,143  0,008  Glycine receptor agonist
0,137  0,003  SULT2A1 substrate
0,134  0,004  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,182  0,056  Phobic disorders treatment
0,235  0,108  Antineoplastic (multiple myeloma)
0,229  0,103  Lipoprotein disorders treatment
0,239  0,114  Metabolic disease treatment
0,221  0,102  Interleukin agonist
0,159  0,040  Antihemorrhagic
0,161  0,046  Adenylate cyclase stimulant
0,116  0,004  Nitric oxide donor
0,168  0,056  Protein kinase stimulant
0,114  0,004  Hypogonadism treatment
0,125  0,016  Bile acid receptor antagonist
0,126  0,020  Tocolytic
0,173  0,072  Antineoplastic (bone cancer)
0,246  0,146  Stroke treatment
0,171  0,071  Phospholipase C inhibitor
0,147  0,049  Aldehyde dehydrogenase inhibitor
0,153  0,056  Bone formation stimulant
0,161  0,070  Antiviral (Herpes)
0,134  0,048  Topoisomerase I inhibitor
0,174  0,089  Sepsis treatment
0,143  0,059  Skin whitener
0,155  0,071  Acute respiratory distress syndrome (ARDS) treatment
0,087  0,005  Pregnane X receptor antagonist
0,179  0,100  Antihypertriglyceridemic
0,132  0,053  Retinopathy treatment
0,144  0,065  Neurotrophic factor
0,125  0,047  Expectorant
0,186  0,110  Antineoplastic (lymphocytic leukemia)
0,105  0,034  Transcription factor NF kappa B stimulant
0,130  0,059  Coagulant
0,130  0,060  Antiviral (Hepatitis B)
0,082  0,015  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,107  0,042  ABCA1 expression enhancer
0,119  0,055  Mucolytic
0,105  0,042  Actinic keratosis treatment
0,079  0,016  Heme oxygenase stimulant
0,197  0,135  Antineoplastic (colorectal cancer)
0,093  0,033  T cell inhibitor
0,233  0,175  Antineoplastic (non-Hodgkin's lymphoma)
0,077  0,023  Andropause treatment
0,090  0,038  Keratolytic
0,083  0,032  Dysmenorrhea treatment
0,143  0,093  Growth hormone agonist
0,066  0,016  Adenosine deaminase inhibitor
0,131  0,086  Antimutagenic
0,181  0,137  Antineoplastic (colon cancer)
0,042  0,004  Hedgehog signaling activator
0,091  0,054  Ornithine decarboxylase inhibitor
0,056  0,020  Microtubule stabilization
0,049  0,015  Farnesoid X receptor agonist
0,149  0,116  Non-steroidal antiinflammatory agent
0,173  0,141  Peptidyltransferase inhibitor
0,158  0,129  Hypolipemic
0,084  0,055  Antiprotozoal activity enhancer
0,108  0,081  Acetylcholine muscarinic antagonist
0,083  0,057  Estrogen-related receptor beta agonist
0,044  0,019  Cholesterol absorption inhibitor
0,155  0,130  Growth factor agonist
0,159  0,135  Free radical scavenger
0,075  0,053  SULT1A2 substrate
0,074  0,052  Antibiotic
0,090  0,069  Posttraumatic stress disorder treatment
0,107  0,086  Cholinergic antagonist
0,131  0,111  Aldose reductase substrate
0,026  0,006  Progesterone receptor B antagonist
0,087  0,068  Paget's disease treatment
0,023  0,005  Telomerase stimulant
0,104  0,087  Acetylcholine antagonist
0,159  0,142  Antineoplastic (non-small cell lung cancer)
0,095  0,078  Beta glucuronidase inhibitor
0,019  0,003  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,024  0,011  Vitamin D receptor antagonist
0,079  0,066  GABA A receptor agonist
0,016  0,004  Progesterone receptor A antagonist
0,203  0,191  GST M1-1 substrate
0,055  0,045  HIV-1 integrase (Strand Transfer) inhibitor
0,018  0,009  Vitamin D receptor agonist
0,042  0,033  Liver X receptor agonist
0,072  0,064  Antitreponemal
0,039  0,031  Liver X receptor alpha agonist
0,049  0,041  Anesthetic inhalation
0,193  0,187  Antithrombotic
0,111  0,105  Antiprotozoal (Trichomonas)
0,108  0,103  Antineoplastic (squamous cell carcinoma)
0,091  0,089  GABA receptor agonist
0,020  0,018  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,066  0,064  CDC25A inhibitor
0,148  0,147  Pneumotoxic
0,187  0,185  Angiogenesis inhibitor

